ClinConnect ClinConnect Logo
Search / Trial NCT01407133

Conventional Repetitive Transcranial Magnetic Stimulation for Tinnitus Treatment

Launched by HOSPICES CIVILS DE LYON · Aug 1, 2011

Trial Information

Current as of May 23, 2025

Completed

Keywords

Neuro Otology Chronic Tinnitus Sensory Disability Repetitive Transcranial Magnetic Stimulation Dose Escalation

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men and women between the ages of 18 and 75 years old;
  • Adequate medical condition (ASA P1 or P2 in Physical Status Classification System);
  • Disabling tinnitus (STSS \> 8/16 or THQ \> 50%), with the following characteristics: continuous, subjective, non-pulsatile; unilateral (or bilateral with unilateral predominance), chronic (duration for at least one year), refractory for usual treatments taken for at least six months;
  • Naive regarding TMS;
  • Able to provide informed consent.
  • Exclusion Criteria:
  • Objective tinnitus or tinnitus with treatable cause;
  • Presence of intracranial or intraocular ferromagnetic materiel or particles (with the exception of dental fillings and MRI-compatible stapedectomy prosthesis);
  • Cardiac pacemaker or other electronic implants (including cochlear implant);
  • Serious heart disease or other unstable major medical condition;
  • Personal history of central nervous system disorder, head injury, stroke or seizures (including childhood febrile seizures);
  • Familial history of epilepsy;
  • Concomitant medication with antidepressants and antipsychotics;
  • Possibility of pregnancy;
  • Known claustrophobia;
  • Others known contraindications to rTMS or brain MRI;
  • Refusal to be informed about the results of anatomical MRI

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon Cedex 03, , France

Pierre Bénite Cedex, , France

Pierre Bénite Cedex, , France

Patients applied

0 patients applied

Trial Officials

Xavier PERROT, MD, PhD

Principal Investigator

Service d'Audiologie et Explorations Orofaciales (Pr. COLLET) - Centre Hospitalier Lyon Sud - Hospices Civils de Lyon

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials